Swisse-Hair Skin Nails Ultiboost 100 Tablets

Product Description

Swisse Ultiboost Hair Skin Nails+ is a premium quality beauty formula with vitamins and minerals specifically formulated to support collagen production and assist in the maintenance of healthy hair, skin and nails. Vitamin C and silica play an integral role in the formation of collagen. Collagen is a major structural protein, important for healthy and strong connective tissue to help maintain skin integrity and appearance. Formulated to help maintain healthy hair, skin and nails along with zinc to assist minor wound healing and skin health. Contains biotin, which helps strengthen soft, brittle nails and reduce breaking and splitting.

Active Ingredients

EACH TABLET CONTAINS

Biotin 2.6 mg, Silicon (from silica-colloidal anhydrous 85.56 mg) 40 mg, Zinc (from zinc gluconate 229.70 mg) 30 mg, Iron (from ferrous fumarate 16.01 mg) 5 mg,Vitamin C (ascorbic acid from calcium ascorbate 60.52 mg) 50 mg, St. Marys Thistle (Silybum marianum) standardised extract equiv. dry fruit 1 g (equiv. flavanolignans calculated as silybin 12 mg)

** No added gluten, lactose, egg, yeast, salt, artificial colours and artificial flavours.

Directions For Use

One tablet daily during or immediately after a meal, or as directed by a healthcare professional.

Warning

Always read the label.

Use only as directed.

Contains zinc, which may be dangerous if taken in large amounts or for a long period.

Not for the treatment of iron deficiency conditions. 

If symptoms persist, see your healthcare practitioner.

About Swisse

Swisse is an Australian success story. It all began with founder Kevin Ring in a humble Melbourne warehouse in 1969. From the outset, our mission was embedded in the Swisse DNA – a dream to make people all over the world healthier and happier. Today, the Swisse product range stretches from top selling men’s and women’s multivitamins and dietary supplements, to sports nutrition, skincare and functional foods. Swisse products are currently available in Australia, New Zealand, China, Singapore, the UK, Italy and the Netherlands, with plans to launch in up to 30 countries in the next five years.